Anthony C. Wood

Hematology

1120 W Michigan St
Indianapolis, IN 46202

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Glucarpidase for treatment of high-dose methotrexate toxicity.

Glucarpidase for treatment of high-dose methotrexate toxicity.

Journal: Blood

Published: July 22, 2024

Inferior Outcomes of EU Versus US Patients Treated With CD19 CAR-T for Relapsed/Refractory Large B-cell Lymphoma: Association With Differences in Tumor Burden, Systemic Inflammation, Bridging Therapy Utilization, and CAR-T Product Use.

Inferior Outcomes of EU Versus US Patients Treated With CD19 CAR-T for Relapsed/Refractory Large B-cell Lymphoma: Association With Differences in Tumor Burden, Systemic Inflammation, Bridging Therapy Utilization, and CAR-T Product Use.

Journal: HemaSphere

Published: October 19, 2022

Outcomes of CD19-Targeted Chimeric Antigen Receptor T Cell Therapy for Patients with Reduced Renal Function Including Dialysis.

Outcomes of CD19-Targeted Chimeric Antigen Receptor T Cell Therapy for Patients with Reduced Renal Function Including Dialysis.

Journal: Transplantation and cellular therapy

Published: July 12, 2022

Primary progression during frontline CIT associates with decreased efficacy of subsequent CD19 CAR T-cell therapy in LBCL.

Primary progression during frontline CIT associates with decreased efficacy of subsequent CD19 CAR T-cell therapy in LBCL.

Journal: Blood advances

Published: January 07, 2022

Anatomic patterns of recurrence in biliary tract cancers: does primary tumor site matter?

Anatomic patterns of recurrence in biliary tract cancers: does primary tumor site matter?

Journal: Journal of gastrointestinal oncology

Published: December 10, 2021

Evaluation of Tumor DNA Sequencing Results in Patients with Gastric and Gastroesophageal Junction Adenocarcinoma Stratified by TP53 Mutation Status.

Evaluation of Tumor DNA Sequencing Results in Patients with Gastric and Gastroesophageal Junction Adenocarcinoma Stratified by TP53 Mutation Status.

Journal: The oncologist

Published: October 05, 2021

Investigational PARP inhibitors for the treatment of biliary tract cancer: spotlight on preclinical and clinical studies.

Investigational PARP inhibitors for the treatment of biliary tract cancer: spotlight on preclinical and clinical studies.

Journal: Expert opinion on investigational drugs

Published: March 04, 2021

Phase I study of the mTOR inhibitor everolimus in combination with the histone deacetylase inhibitor panobinostat in patients with advanced clear cell renal cell carcinoma.

Phase I study of the mTOR inhibitor everolimus in combination with the histone deacetylase inhibitor panobinostat in patients with advanced clear cell renal cell carcinoma.

Journal: Investigational new drugs

Published: August 28, 2019

Therapeutic Targeting of TFE3/IRS-1/PI3K/mTOR Axis in Translocation Renal Cell Carcinoma.

Therapeutic Targeting of TFE3/IRS-1/PI3K/mTOR Axis in Translocation Renal Cell Carcinoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: January 30, 2018

Showing 1-9 of 9

Last Updated: 09/26/2026